Scottish Antisense Firm ExpressOn Closing After Failed Funding Deal with MMI | GenomeWeb

NEW YORK, April 14 (GenomeWeb News) - Scottish company ExpressOn, which makes gene-blocking antisense products, is in the process of shutting down operations in the wake of a failed deal with Cambridge-based Medical Marketing International to fund further commercialization of ExpressOn's products, according to a news report.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.